Niagen Bioscience Balance Sheet (2011-2026) | NAGE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	38.78M	33.10M	28.22M	20.99M	17.07M	13.26M	20.44M	23.14M	26.41M	26.77M	27.32M	27.57M	27.89M	32.40M	44.66M	55.62M	60.47M	64.29M	64.79M	66.55M
Cash & Current Investments (Quarter)	38.78M	33.10M	28.22M	20.99M	17.07M	13.26M	20.44M	23.14M	26.41M	26.77M	27.32M	27.57M	27.89M	32.40M	44.66M	55.62M	60.47M	64.29M	64.79M	66.55M
Receivables - Net (Quarter)	6.00M	5.29M	5.23M	6.31M	4.23M	4.74M	3.10M	9.22M	2.80M	2.90M	2.80M	6.60M	7.82M	7.10M	7.77M	7.05M	9.70M	8.51M	9.74M	13.10M
Receivables - Other (Quarter)	2.20M	2.30M	2.10M	2.30M	1.30M	2.40M	3.10M	3.50M
Receivables (Quarter)	8.20M	7.59M	7.33M	8.61M	5.53M	7.14M	6.20M	12.72M	2.80M	2.90M	2.80M	6.60M	7.82M	7.10M	7.77M	7.05M	9.70M	8.51M	9.74M	13.10M
Raw Materials (Quarter)
Work In Process (Quarter)
Finished Goods (Quarter)
Inventory (Quarter)	12.18M	12.68M	13.60M	15.31M	15.75M	15.64M	14.68M	11.91M	11.97M	12.62M	14.53M	12.49M	11.51M	10.54M	9.19M	11.19M	14.41M	18.79M	20.42M	24.02M
Prepaid Assets (Quarter)	0.97M	1.76M	1.86M	1.91M	1.46M	4.26M	2.97M	2.29M	1.89M	2.18M	2.45M	2.31M	2.09M	2.10M	2.48M	2.37M	2.14M	2.03M	1.31M	1.49M
Current Assets (Quarter)	57.93M	52.84M	48.91M	44.52M	38.51M	37.90M	46.57M	46.56M	46.38M	47.18M	49.53M	48.98M	49.30M	52.13M	64.10M	76.22M	86.68M	93.62M	96.81M	105.12M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	3.15M	3.08M	3.00M	2.94M	2.90M	2.79M	2.80M	2.69M	2.50M	2.29M	2.14M	2.00M	1.84M	1.72M	1.72M	1.66M	1.63M	1.50M	1.32M	1.30M
Long-Term Investments (Quarter)
Intangibles (Quarter)	0.96M	0.91M	0.86M	0.81M	0.76M	0.71M	0.67M	0.63M	0.59M	0.55M	0.51M	0.47M	0.43M	0.40M	0.36M	0.32M	0.28M	0.25M	5.66M	5.49M
Goodwill & Intangibles (Quarter)	0.96M	0.91M	0.86M	0.81M	0.76M	0.71M	0.67M	0.63M	0.59M	0.55M	0.51M	0.47M	0.43M	0.40M	0.36M	0.32M	0.28M	0.25M	5.66M	5.49M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	0.20M	0.20M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.15M	0.42M	0.15M	0.15M
Non-Current Assets (Quarter)	7.91M	7.62M	8.94M	8.41M	8.11M	7.76M	7.49M	7.20M	6.79M	6.30M	5.43M	5.10M	4.73M	4.39M	4.18M	5.12M	4.85M	4.52M	9.60M	9.21M
Assets (Quarter)	65.84M	60.45M	57.84M	52.93M	46.61M	45.66M	54.06M	53.77M	53.17M	53.48M	54.96M	54.08M	54.03M	56.52M	68.28M	81.34M	91.53M	98.14M	106.41M	114.33M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	9.97M	10.80M	10.42M	9.78M	10.20M	9.12M	9.68M	8.95M	10.03M	9.20M	10.23M	7.90M	8.11M	6.90M	8.53M	10.63M	13.68M	12.74M	10.80M	13.28M
Notes Payables (Quarter)
Payables (Quarter)	9.97M	10.80M	10.42M	9.78M	10.20M	9.12M	9.68M	8.95M	10.03M	9.20M	10.23M	7.90M	8.11M	6.90M	8.53M	10.63M	13.68M	12.74M	10.80M	13.28M
Accumulated Expenses (Quarter)	5.57M	6.33M	6.48M	8.13M	6.70M	6.76M	7.34M	8.61M	8.08M	9.19M	9.49M	10.46M	8.62M	9.59M	7.82M	9.05M	7.38M	8.70M	7.72M	7.62M
Short term Debt (Quarter)
Current Leases (Quarter)	0.01M	0.01M	0.02M	0.63M	0.65M	0.01M	0.68M	0.70M	0.01M	0.85M	0.69M	0.01M	0.97M	1.01M	0.01M	0.94M	0.96M	0.00M	1.00M	1.03M
Current Deferred Revenue (Quarter)	0.21M	0.17M	0.16M	0.14M	0.17M	0.16M	0.16M	0.15M	0.17M	0.19M	0.20M	0.23M	0.16M	0.18M	0.61M	0.21M	0.30M	0.29M	0.40M	0.38M
Total Current Liabilities (Quarter)	16.23M	17.77M	17.61M	18.69M	17.73M	16.73M	17.87M	18.42M	19.06M	19.44M	20.62M	19.45M	17.87M	17.70M	17.95M	20.84M	22.33M	22.71M	19.92M	22.82M
Non-Current Liabilities
Capital Leases (Quarter)	0.01M	0.01M					0.02M	0.02M	0.02M	0.01M	0.01M	0.01M	0.01M	0.00M
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)	4.44M	4.35M	4.35M	4.35M	4.23M	4.23M	3.96M	3.96M	3.81M	3.81M	3.30M	3.31M	3.31M	2.58M	2.60M	2.58M	2.67M	2.67M	2.67M	2.57M
Liabilities from Discontinued Operations (Quarter)
Non-Current Deferred Tax Liability (Quarter)
Operating Leases (Quarter)	3.50M	3.30M	4.15M	4.60M	4.53M	4.37M	3.54M	4.10M	3.90M	3.80M	3.30M	2.36M	3.10M	2.88M	2.60M	3.52M	3.30M	3.10M	1.81M	2.60M
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)
Total Liabilities (Quarter)	23.70M	25.00M	26.11M	27.05M	25.84M	24.64M	25.39M	25.75M	26.02M	26.18M	26.51M	25.13M	23.32M	22.15M	22.18M	25.99M	27.33M	27.46M	29.87M	32.00M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	42.14M	35.45M	31.73M	25.88M	20.78M	21.02M	28.67M	28.02M	27.15M	27.31M	28.46M	28.95M	30.72M	34.37M	46.09M	55.34M	64.19M	70.68M	76.53M	82.33M
Shareholder's Equity (Quarter)	42.14M	35.45M	31.73M	25.88M	20.78M	21.02M	28.67M	28.02M	27.15M	27.31M	28.46M	28.95M	30.72M	34.37M	46.09M	55.34M	64.19M	70.68M	76.53M	82.33M
Liabilities and Shareholders Equity (Quarter)	65.84M	60.45M	57.84M	52.93M	46.61M	45.66M	54.06M	53.77M	53.17M	53.48M	54.96M	54.08M	54.03M	56.52M	68.28M	81.34M	91.53M	98.14M	106.41M	114.33M
Retained Earnings (Quarter)	-154.77M	-163.63M	-168.95M	-176.69M	-183.09M	-184.07M	-185.49M	-187.42M	-189.62M	-190.57M	-190.46M	-190.95M	-190.97M	-189.09M	-181.91M	-176.85M	-173.24M	-168.66M	-164.53M	-158.21M
Treasury Shares (Quarter)							0.18M		0.77M	0.17M	0.59M	0.89M	0.78M	0.68M	0.61M	0.34M	1.52M	1.52M	0.27M	0.49M

Research Tools

Developers

Niagen Bioscience Balance Sheet (2011-2026) | NAGE

Research Tools

Developers

Niagen Bioscience Balance Sheet (2011-2026) | NAGE

Create an account

Sign In

Reset Password